Work

303P Three-year clinical outcomes of preoperative SBRT and immunochemotherapy in stage II-III NSCLC (SACTION01 trial)

Year: 2026

Type: article

Abstract: Preoperative stereotactic body radiation (SBRT) has shown to improve the short-term outcomes for resectable Non-Small-Cell Lung Cancer (NSCLC) patients who received induction immunochemotherapy. However, its long-term effectiveness remains unclear. Here we present the 3-year survival outcomes of the SACTION01 trial (NCT05319574).

Source: ESMO Open

DOI: 10.1016/j.esmoop.2026.106613